BPH Medications: Alpha-Blockers, 5-ARIs, and Tadalafil

Three main classes of prescription drugs treat benign prostatic hyperplasia (BPH) and the urinary symptoms that come with it: alpha-blockers, 5-alpha reductase inhibitors (5-ARIs), and a specific phosphodiesterase-5 (PDE5) inhibitor called tadalafil. Each works through a different mechanism, kicks in on a different timeline, and carries a different set of trade-offs. Which one your doctor recommends depends on prostate size, how bothersome your symptoms are, whether you also have erectile dysfunction, and how you feel about the side-effect profile of each drug.

Alpha-Blockers and Fast Symptom Relief

Alpha-blockers are usually the first drug prescribed when BPH symptoms start interfering with daily life. Names you’ll see include tamsulosin, alfuzosin, doxazosin, terazosin, and silodosin. They work by relaxing smooth muscle in the prostate and bladder neck, which loosens the squeeze on the urethra and lets urine flow more freely. They do not shrink the prostate. What they do is reduce the “dynamic” component of obstruction, the part caused by muscle tension rather than tissue bulk.

The practical upside is speed. Alpha-blockers start improving urinary flow and symptom scores within days to weeks, making them the better short-term performers compared to drugs that actually reduce prostate size.¹ Direct comparative trials confirm that in the short term, alpha-blockers outperform finasteride on symptom score reduction.² The downside is that they never address the underlying growth of the gland. If the prostate keeps enlarging over the years, alpha-blockers alone may eventually stop being enough.

Among the alpha-blockers, tamsulosin and silodosin are “uroselective,” meaning they preferentially target the receptor subtype concentrated in prostate tissue. That selectivity tends to produce fewer blood-pressure-related side effects like dizziness upon standing. Older agents like doxazosin and terazosin are less selective and can lower blood pressure more broadly, which is sometimes useful in men who also have hypertension but is a nuisance for those with normal blood pressure. Alfuzosin sits somewhere in between and has been noted for minimal blood-pressure and sexual-function side effects even in aging men with other health conditions.³

5-Alpha Reductase Inhibitors and Prostate Shrinkage

If alpha-blockers address the muscle-tension side of obstruction, 5-ARIs go after the tissue-bulk side. Finasteride and dutasteride both block the enzyme that converts testosterone into dihydrotestosterone (DHT), a hormone with a much stronger effect on prostate tissue growth. DHT binds more tightly to androgen receptors in the prostate and drives cell proliferation, so reducing it causes the gland to gradually shrink.⁴ Finasteride blocks one form of the enzyme, while dutasteride blocks both known forms, earning it the label “dual inhibitor.”⁵

The catch is patience. 5-ARIs have a slow onset of effect, often taking three to six months before you notice meaningful improvement.⁶ That timeline frustrates many men, and it’s one reason alpha-blockers are usually started first or alongside a 5-ARI. The payoff for patience is significant, though: in a large four-year trial, finasteride cut the risk of acute urinary retention (a painful inability to urinate at all) by about 57% and the need for BPH-related surgery by about 55% compared to placebo.⁷ Those are the outcomes that matter most to men trying to avoid the operating room.

Tadalafil for BPH Symptoms

Tadalafil, better known as the erectile dysfunction drug Cialis, has a separate approval for BPH-related urinary symptoms at a dose of 5 mg taken once daily. The mechanism isn’t fully pinned down, but PDE5 inhibition appears to relax smooth muscle in the prostate, bladder neck, and surrounding blood vessels, increase blood flow to the lower urinary tract, and quiet overactive bladder nerve signaling.⁸

In dose-finding studies, tadalafil at 5 mg and above produced meaningful improvements in both irritative and obstructive symptom subscores, quality-of-life measures, and BPH impact indexes compared to placebo.⁹ What makes tadalafil unique among BPH drugs is that it simultaneously treats erectile dysfunction, which is extremely common in the same age group. It’s the only single pill that addresses both problems at once, and it avoids the sexual side effects associated with alpha-blockers and 5-ARIs.¹⁰ Its symptom-relief effect doesn’t depend on whether the man actually has ED; it works for BPH symptoms regardless.

Why Combination Therapy Often Wins Long-Term

For men with larger prostates or more severe symptoms, doctors frequently combine an alpha-blocker with a 5-ARI. The logic is straightforward: the alpha-blocker provides fast relief while the 5-ARI slowly shrinks the gland. Long-term data show the combination working well on all measured parameters.¹¹

The most compelling data come from a ten-year follow-up comparing alpha-blocker monotherapy to combination therapy. Acute urinary retention occurred in about 14% of men on alpha-blockers alone versus about 3% on the combination, a roughly 79% lower hazard. BPH-related surgery was needed in about 8% of the alpha-blocker group versus about 3% of the combination group, a roughly 62% lower hazard.¹² The difference in surgery rates only became significant after about seven years, which is a useful reminder that BPH is a long game and that drugs preventing tissue growth need time to prove their value.

Sexual Side Effects and Mood Changes

The side effect that concerns men most is sexual dysfunction, and the drugs differ sharply here. Alpha-blockers can cause retrograde ejaculation (where semen goes into the bladder instead of out), particularly tamsulosin. This is annoying but not harmful, and it reverses when the drug is stopped. 5-ARIs, on the other hand, carry a broader sexual side-effect profile. A systematic review found that erectile dysfunction, decreased libido, and reduced ejaculate volume were reported in roughly 3% to 16% of men taking finasteride or dutasteride.¹³ That’s a wide range, partly because studies define and measure these side effects differently, but it’s a real concern for many men.

There’s also growing attention to mood effects from 5-ARIs. A prospective study found that finasteride treatment significantly increased depression scores on standardized rating scales, suggesting the drug might trigger depressive symptoms in some men.¹⁴ A large pharmacovigilance analysis of adverse-event reports found a disproportionality signal for suicidality and psychological adverse events in finasteride users, though it’s worth noting that the strongest signals appeared in younger men taking the drug for hair loss rather than in older men with BPH.¹⁵ The BPH population did not show the same elevated signal for suicidality in that analysis. Still, if you have a history of depression or notice mood changes after starting a 5-ARI, it’s something to bring up with your doctor sooner rather than later.

The Floppy Iris Problem With Cataract Surgery

Here’s a side effect that blindsides many patients because it involves an entirely different organ: the eye. Alpha-blockers, especially tamsulosin, can cause a condition called intraoperative floppy iris syndrome (IFIS) during cataract surgery. The same receptor subtype that tamsulosin targets in the prostate also exists in the iris dilator muscle. Blocking it causes the iris to lose tone and billow around during surgery, making the procedure more difficult and raising the risk of serious complications like retinal detachment or losing a lens fragment.¹⁶

Other alpha-blockers like doxazosin and alfuzosin can also contribute to IFIS, but the risk is lower because they have less affinity for the specific receptor subtype in the iris.¹⁷ If you’re on tamsulosin and need cataract surgery, tell your ophthalmologist immediately. The effect can persist even after stopping the drug, so simply pausing tamsulosin before surgery isn’t a reliable fix. Surgeons who know about the exposure ahead of time can use techniques to manage it, but being caught off guard significantly raises complication risk.

Adding Drugs for Storage Symptoms

BPH medications tackle obstruction, but many men with enlarged prostates also develop “storage” symptoms: urgency, frequency, and needing to get up multiple times at night. These overlap with overactive bladder (OAB), and alpha-blockers alone don’t always resolve them. In those cases, doctors may add a second medication that directly targets bladder muscle activity.

Mirabegron, a beta-3 agonist that relaxes the bladder muscle, has shown clear benefits when added to tamsulosin. A pooled analysis found that the combination reduced the number of daily urgency episodes, improved overall OAB symptom scores, and increased the volume voided per trip. The combination was well tolerated, though it slightly increased the amount of urine left in the bladder after voiding.¹⁸ A randomized trial comparing tamsulosin plus mirabegron against tamsulosin alone confirmed significantly better improvements in urgency, OAB symptom scores, and quality of life after eight weeks.¹⁹ Anticholinergics like darifenacin are another option for the same purpose, and an eight-week study found that tamsulosin plus darifenacin was both effective and safe in men with BPH and accompanying OAB.²⁰

Blood Pressure Interactions With PDE5 Inhibitors

If you’re taking an alpha-blocker for BPH and also use a PDE5 inhibitor for erectile dysfunction (sildenafil, tadalafil, or vardenafil), the two drugs can interact to drop blood pressure further than either one alone. Some patients develop orthostatic hypotension, a sharp fall in pressure when standing that can cause dizziness or fainting. Precautions apply to all three PDE5 inhibitors, though some evidence suggests the interaction matters less if the patient has been on a stable alpha-blocker dose for a while.²¹

A systematic review and meta-analysis found that combining an alpha-blocker with a PDE5 inhibitor produced clinically significant hemodynamic changes more often than alpha-blocker monotherapy. However, the rate of positive orthostatic tests (the formal assessment of blood pressure upon standing) was not statistically different between the groups, and actual hypotension-related adverse events were similar between groups as well.²² So the theoretical risk is real, but the clinical impact is more modest than the warnings might suggest. Your prescriber will typically have you established on one drug before adding the other, and may adjust timing so the two don’t peak in your blood simultaneously.

How 5-ARIs Affect PSA Screening

Both finasteride and dutasteride lower your prostate-specific antigen (PSA) level, the blood marker used to screen for prostate cancer. This matters because a declining PSA on a 5-ARI might mask a rise that would otherwise trigger further investigation. In the Prostate Cancer Prevention Trial, the adjustment factor needed to restore PSA values to their “untreated” equivalent started at about 2 (meaning you’d multiply the measured PSA by 2) after two years on finasteride, and climbed to about 2.5 after seven years.²³ Your doctor needs to know you’re on a 5-ARI to interpret PSA results correctly. If you see a new provider who doesn’t have your medication history, mention it before any PSA blood draw.

Why So Many Men Stop Taking Their Medication

Adherence to BPH medication is surprisingly poor. In a large population-based cohort, only about 29% of patients who had been on therapy for at least six months were still adherent at one year. By five years, adherence dropped to about 15% for alpha-blockers, 8% for 5-ARIs, and just 3% for combination therapy.²⁴ The worse adherence with combination therapy likely reflects the burden of taking more pills and experiencing more side effects.

Stopping matters clinically. Discontinuing drug treatment was an independent risk factor for hospitalization and surgery for BPH, roughly doubling to tripling the risk depending on the outcome.²⁵ A separate analysis found that only about 40% of men were adherent overall, with those taking multiple medications and finasteride showing better adherence, while doxazosin, terazosin, and tamsulosin were each associated with worse adherence. Younger men and those who switched medications were more likely to stop entirely.²⁶ The takeaway here is that if a drug is causing side effects you can’t tolerate, talk to your doctor about switching rather than simply quitting. Going untreated raises the risk of the complications these drugs are meant to prevent.

Saw Palmetto and Herbal Supplements

Saw palmetto extract is the most popular herbal supplement marketed for prostate health, and many men try it before or instead of prescription drugs. The evidence, though, is a mess. A well-designed randomized trial published in the New England Journal of Medicine found no significant difference between saw palmetto and placebo on any measured outcome: symptom scores, urinary flow rate, prostate size, residual volume after voiding, quality of life, or PSA levels over one year.²⁷ A review of the broader literature noted that results have been inconsistent, at least partly because there is no standardized formula for saw palmetto extract, meaning what’s in one brand’s capsule may be quite different from another’s.²⁸

One recent randomized trial did find that a beta-sitosterol-enriched saw palmetto oil produced significant improvements in symptom scores, post-void residual volume, PSA, and urine flow rates compared to placebo over 12 weeks.²⁹ That result suggests the active compounds may matter more than the label “saw palmetto,” and that standardization of the extract might be the key variable. But until larger, longer trials confirm this, saw palmetto can’t be recommended as a substitute for proven prescription medications, especially in men whose symptoms are moderate to severe.

When to Consider a Procedure Instead

Medications are the standard first step for BPH, and at generic prices, common agents like tamsulosin and finasteride can cost as little as a few dollars per month. That makes drug therapy economically favorable compared to procedures in the short run. However, pharmacologic therapies produce modest improvements in objective flow measures and expose men to years of cumulative costs and side effects, with some men eventually needing a procedure anyway.³⁰

Minimally invasive surgical therapies (often abbreviated MIST) include options like water vapor thermal therapy (Rezūm), prostatic urethral lift (UroLift), and several newer approaches. A review of the literature concluded that MIST provides symptom relief at least as good as medications without requiring daily pill adherence, and without the sexual or systemic side effects of long-term drug use.³¹ A cost-effectiveness analysis found that starting with water vapor thermal therapy generated more quality-adjusted life years at lower lifetime cost than starting with medications and escalating to a procedure later.³²

None of this means every man should skip medications and head straight for a procedure. For mild symptoms, drug therapy is reasonable and reversible. But for men with moderate to severe symptoms, large prostates, or poor medication tolerance, having a conversation about MIST early rather than viewing it only as a last resort can lead to better long-term outcomes and lower total cost.

Choosing Based on Prostate Size and Symptom Pattern

Not every BPH medication makes sense for every prostate. Alpha-blockers work regardless of prostate size because they target muscle tension rather than tissue volume. 5-ARIs, by contrast, are most useful for men with demonstrably enlarged prostates (typically above 30–40 grams on imaging or exam), because the tissue-shrinkage benefit is proportional to how much excess tissue there is to shrink. Prescribing a 5-ARI to a man with a small prostate and mild symptoms often creates side-effect risk without much reward.

Symptom pattern also guides decisions. Men whose main complaints are slow stream, hesitancy, and straining (obstructive symptoms) tend to respond best to alpha-blockers or combination therapy. Men with primarily urgency, frequency, and nocturia (storage symptoms) may need a bladder-targeted add-on like mirabegron or an anticholinergic, as covered above. And men bothered by both BPH symptoms and erectile dysfunction have a unique one-pill option in tadalafil 5 mg daily, which avoids the sexual side effects of the other drug classes entirely.

The landscape of BPH drugs is wider than most men realize when they first hear “enlarged prostate.” Having a clear sense of what each class does, how fast it works, and what it might cost you in terms of side effects gives you a better starting point for the conversation with your doctor, and a better chance of finding a regimen you’ll actually stick with.